Skip to main content
. 2017 Apr 24;7:46698. doi: 10.1038/srep46698

Figure 4. 15-HETE increases proliferation and migration of BMVECs in a PI3K/Akt-dependent manner.

Figure 4

(a) In BMVECs under OGD conditions, both endogenous and exogenous 15-HETE (1μmol/L) increased PI3K/Akt expression. (n = 4, *p < 0.05, **p < 0.01). Values are represented as the mean ± S.E.M. (b) Pretreatment with LY-294002 blocked the effects of 15-HETE on cell migration. (c) The increased PCNA expression after 15-HETE under OGD was blocked by the PI3K/Akt inhibitor. (d) Pretreatment of LY-294002 blocked the exogenous 15-HETE-induced BrdU incorporation. (n = 4, *p < 0.05, **p < 0.01). Values are represented as the mean ± S.E.M. (e) Flow cytometry for cell-cycle analysis indicated that 15-HETE stimulated BMVEC progression into G2/M + S phase, and this effect was blocked by LY-294002. (f) LY-294002 also blocked the increase in cyclin A or (g) cyclin D, induced by 15-HETE. (n = 4, *p < 0.05, **p < 0.01). Values are represented as the mean ± S.E.M.